Looking to reduce your Medicare costs in retirement? Here are 3 smart moves
Many seniors no longer have a mortgage to pay for and can do more home maintenance themselves since they're not busy working. And not having to report to a job means not spending money on a daily commute.
But if there's one expense that tends to increase among retirees, it's healthcare. For a 65-year-old leaving the workforce in 2024, Fidelity puts the average cost of healthcare in retirement at $165,000. And part of that includes expenses related to Medicare.
The good news, though, is that you can take steps to lower your healthcare spending as a Medicare enrollee. Here's how.
1. Sign up on time
Although Medicare coverage beings at 65, you can sign up a bit earlier. Your initial enrollment window for Medicare starts three months before the month you turn 65 and ends three months after that month.
It pays to enroll in Medicare on time not just to avoid a gap in coverage, but also, to avoid surcharges on your premiums. If you don't enroll on time, you could face a 10% surcharge for each 12-month period you were eligible for Part B but didn't enroll. And there can be surcharges if you fail to enroll in a Part D drug plan on time.
2. Understand your plan's benefits inside and out
If you decide to stick with original Medicare, you'll need a Part D drug plan to go along with Parts A (hospital care) and B (outpatient care). If you decide to enroll in Medicare Advantage, you should get all-in-one coverage through that plan, including prescriptions.
While the rules that apply to Parts A and B are universal for all enrollees, each Medicare Advantage and Part D plan sets its own rules and has its own benefits. It's important to understand those thoroughly so you're able to take advantage of the perks you're paying for without incurring unwanted costs.
For example, it's common for Medicare Advantage plans to stick you with higher costs for out-of-network care. In some cases, you might even have to foot the whole bill yourself, so it's important to know what your plan will and won't cover.
Similarly, with Part D plans, medications are typically grouped into different tiers that come with different costs. It's important to see what costs you're looking at, since there may be a preferred medication that will result in less out-of-pocket spending on your part.
3. Take advantage of fall open enrollment each year
The Medicare Advantage or Part D drug plan you sign up for isn't coverage you're stuck with for life. Each year, Medicare enrollees can make changes to Advantage and Part D plans during fall open enrollment, which takes place between Oct. 15 and Dec. 7.
During open enrollment, you can switch from one Medicare Advantage plan to another or even drop Medicare Advantage altogether if you're not a fan. You can also make changes to your Part D coverage.
Some people choose to sit out open enrollment because they're happy with their existing coverage. But you never know when a more cost-effective plan might become available. So it pays to do some research during open enrollment each year, no matter what.
While healthcare might end up being a large retirement expense, there are ways you can reduce it as a Medicare enrollee. Read up on Medicare ahead of retirement so you can position yourself to make the most of it while shaving down your costs.
The Motley Fool has a disclosure policy.
The Motley Fool is a USA TODAY content partner offering financial news, analysis and commentary designed to help people take control of their financial lives. Its content is produced independently of USA TODAY.
The $23,760 Social Security bonus most retirees completely overlook
Offer from the Motley Fool: If you're like most Americans, you're a few years (or more) behind on your retirement savings. But a handful of little-known "Social Security secrets"could help ensure a boost in your retirement income.
One easy trick could pay you as much as $23,760 more... each year! Once you learn how to maximize your Social Security benefits, we think you could retire confidently with the peace of mind we're all after. JoinStock Advisorto learn more about these strategies.
View the "Social Security secrets" »
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Business News
3 hours ago
- Time Business News
Speculation Mounts Around Possible Clover Health
July 5, 2025 — New York — Talk of a potential partnership between Clover Health's AI division, Counterpart Health, and insurance giant Humana has gained traction after a string of digital breadcrumbs and recent corporate remarks ignited speculation throughout the healthcare and investment communities. While neither company has made a formal announcement, the circumstantial evidence has grown too aligned to ignore, hinting that Humana may be preparing to deploy Clover's AI platform across its vast Medicare Advantage operations. If true, the move could be a game-changer for both companies: a potential multi-billion-dollar opportunity for recently struggling Humana, and a defining moment in Clover Health's reinvention from insurance underdog to healthcare tech disruptor. The speculation began after Humana's June 16 investor meeting, during which executives outlined the company's path forward amid growing challenges. Humana has recently been under significant pressure due to declining Medicare Advantage Star Ratings, rising medical costs, and an increasingly complex regulatory environment. To address these headwinds, the company presented a long-term strategy focused on operational efficiency, automation, and simplification. Humana stated it would 'leverage outsourcing and technology to simplify and automate processes… while driving efficiencies'. What made the presentation even more notable was the timeline Humana laid out. The company projected a gradual improvement in cost efficiency – starting with baseline progress in 2026, and a full impact by 2028. That timeline is nearly identical to the three-year cost savings arc marketed by Counterpart Health, which claims its AI can reduce a payer's Medical Cost Ratio by 7% in year two and up to 15% by year three. While Humana did not mention specific partners, the language prompted the beginning of the speculation. The rumor mill kicked into high gear this week when a publicly available subdomain scan of Counterpart Health's website revealed a curious pattern. Alongside previously announced partners like Duke Connected Care, The Iowa Clinic, and Southern Illinois Healthcare, a number of new subdomains appeared bearing the Humana name. These backend URLs indicate that technical infrastructure might be under development to support a potential relationship between Counterpart and Humana. Notably, the same pattern of subdomains was observed prior to official announcements for Duke, Iowa Clinic, and Southern Illinois Healthcare, all of which later confirmed deals with Counterpart Health. While these web addresses alone don't confirm a deal, their presence strongly suggests that backend systems and integrations are potentially being developed in anticipation of one. Clover Health has touted its Counterpart Assistant platform as a game-changing clinical AI tool that can reduce a payer's Medical Cost Ratio by up to 15%. For context, Clover Health itself posted an MCR of 75.1% in 2024, one of the most efficient in the industry. Meanwhile, Humana has struggled with an increasing MCR due to a variety of headwinds. If Humana were to achieve even a fraction of the cost savings that Clover Health claims are possible, the financial impact could be enormous for the company – potentially saving billions annually. For Clover Health, such a partnership would represent a dramatic turning point. The company, which went public via SPAC in 2021, has spent years battling poor investor sentiment, regulatory scrutiny, and heavy skepticism over its long-term viability. Once seen as just another Medicare Advantage insurer, Clover has been actively repositioning itself around its AI platform, Counterpart Assistant – a tool designed to centralize patient data, assist physicians with real-time clinical insights, and reduce avoidable medical costs. The company attributes its own low MCR of 75.1% to this technology and has begun licensing it to external payers and provider groups under its Counterpart Health brand. A deal with Humana – one of the largest Medicare Advantage organizations in the country – would give Clover Health a level of validation it has never experienced. It would instantly elevate the perception of the company from a traditional insurer to a high-margin, health-AI disrupting SaaS. Investors would no longer value Clover based on insurance metrics, but rather on recurring software revenue, gross margins, and enterprise tech multiples. Although neither Humana nor Clover has commented publicly, and no regulatory filings have confirmed a formal agreement, the emerging pattern is increasingly difficult to ignore: a shared strategic direction, an almost identical cost-cutting timeline, and Humana's digital infrastructure woven into Counterpart Health's operations. If the partnership is ultimately validated, it could mark a major milestone for AI in healthcare – and potentially the long-awaited inflection point in the turnaround journeys of both Clover Health and Humana. TIME BUSINESS NEWS
Business Insider
a day ago
- Business Insider
These 3 Catalysts Could Push UnitedHealth Stock (UNH) Higher
UnitedHealth Group (UNH), one of the largest health insurance and services companies in the U.S., has had a tough year so far. But there are three key catalysts that could help the stock bounce back in the next year or two. These include better-than-expected Medicare Advantage payments, a leadership change at its Optum Health division, and a more stable political environment around healthcare policy. Each of these developments could help UnitedHealth recover from recent setbacks and regain investor confidence. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. The first big catalyst is the improved Medicare Advantage (MA) payment outlook. Earlier this year, U.S. regulators announced a 5.06% rate increase for MA plans in 2026, which was much higher than the 2.23% previously expected. This is important because UnitedHealth relies heavily on MA plans for revenue, through both its insurance business and its Optum services. As a result, higher rates should ease pressure on earnings, especially after a tough 2025 that has been marked by increased medical costs and regulatory investigations. Simply put, more funding means more breathing room for UnitedHealth's bottom line. The second catalyst is a leadership shakeup at Optum Health. After struggling with lower patient volumes and billing issues, UnitedHealth named Patrick Conway, an experienced healthcare executive, as CEO of Optum Health. The hope is that new leadership will help stabilize the business and boost performance. Finally, the third positive factor is reduced regulatory risk. A proposed 25% funding cut to Medicaid and ACA programs was blocked in the U.S. Senate, which helps remove uncertainty for companies like UnitedHealth. When you put it all together—better funding, stronger leadership, and fewer policy threats—UnitedHealth looks better positioned for a recovery. What Is the Future of UNH Stock? Turning to Wall Street, analysts seem to agree that the stock can recover since they have a Moderate Buy consensus rating on UNH stock based on 18 Buys, seven Holds, and one Sell assigned in the past three months. Furthermore, the average UNH price target of $361.91 per share implies 17.2% upside potential.
Gizmodo
2 days ago
- Gizmodo
The Great American EV Fire Sale Is About to Begin
If you are thinking about buying an electric vehicle, the clock is now ticking. President Donald Trump's 'One Big Beautiful Bill' has officially passed Congress, and with it, a countdown that will kill the popular $7,500 federal tax credit for new electric vehicles. You now have less than three months to act. The tax credit officially expires on September 30, 2025. Initially, there were rumors the EV credits would last 180 days from when the bill was signed, a six-month grace period. This law is the centerpiece of Trump's second term, a legislative victory he can claim alongside his mass deportation initiatives as a promise kept to his base. It includes sweeping changes to the American economy, including cuts to social programs like Medicare and new work requirements for food stamp recipients. But one of its most immediate and tangible impacts is a full scale assault on clean energy incentives, and walks back some of the progress made under the Inflation Reduction Act, which previously supercharged EV sales with consumer-friendly subsidies. For consumers, the most significant change is the termination of the EV tax credit. While it was initially rumored the credit might be phased out over six months, the final version of the bill accelerates the timeline dramatically. After September 30, the $7,500 credit for new EVs will be gone. The smaller $4,000 credit for used EVs will also disappear on the same date. The bad news for clean energy does not stop there. The 30% tax credit for rooftop solar installations is now set to end on December 31, 2025, as are incentives for geothermal heat pumps and other home energy devices. The new law also dismantles the regulatory framework that has pushed automakers to produce more electric vehicles. It effectively guts the federal Corporate Average Fuel Economy (CAFE) standards by reducing the penalties for noncompliance to zero. Previously, automakers who failed to meet fuel efficiency targets had to pay steep fines or buy regulatory credits from more efficient companies like Tesla. Now, that financial pressure is gone. In a related move, Congress has revoked the EPA waivers that allowed California and the 17 other states that follow its lead to enforce stricter emissions rules, including Zero Emission Vehicle (ZEV) mandates. These state level programs required automakers to sell a certain percentage of zero emission vehicles or purchase credits from competitors. Without the federal waivers, these state mandates are no longer legally enforceable. For automakers, this means the financial incentive to produce and sell EVs has been significantly weakened. For a company like Tesla, which earned substantial profits in recent years from selling these credits to less compliant automakers, it means a key revenue stream has vanished. But for the average person, the message is much simpler: the era of federally subsidized electric vehicles is coming to a very abrupt end. If you're in the market for an EV, this is your last call. After September 30, the $7,500 and $4,000 tax breaks disappear. And unless there's a dramatic shift in power, they aren't coming back anytime soon.
